- Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension
- Highlights From the Circulation Family of Journals
- Letter by He et al Regarding Article, “Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema”
- Recognized Outstanding Reviewers for Circulation in 2025
- Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification
- Letter by Ran et al Regarding Article, “Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema”
- An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization
- Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution
- Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?
- Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study
- Polycystic Ovarian Syndrome and the Long-term Risk of Arrhythmias
- Association of Pre-Fontan Hemodynamics With Long-Term Outcomes After Fontan Palliation: A Study From the Pediatric Cardiac Care Consortium
- 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Reassessing the First Step: Lessons From ES-BempedACS and the Era of Multi-Mechanism LDL-C Lowering
- Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction
